Spok Holdings, Inc. (SPOK)
USD 15.37
(1.59%)
USD 15.37
(1.59%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 63.91 Million USD | -11.72% |
| 2022 | 72.39 Million USD | -2.77% |
| 2021 | 74.46 Million USD | -2.89% |
| 2020 | 76.67 Million USD | 9.89% |
| 2019 | 69.77 Million USD | 31.27% |
| 2018 | 53.15 Million USD | -11.45% |
| 2017 | 60.03 Million USD | -9.04% |
| 2016 | 66 Million USD | 16.06% |
| 2015 | 56.86 Million USD | -3.33% |
| 2014 | 58.83 Million USD | 3.31% |
| 2013 | 56.94 Million USD | -20.03% |
| 2012 | 71.2 Million USD | -27.06% |
| 2011 | 97.62 Million USD | 110.99% |
| 2010 | 46.26 Million USD | -15.5% |
| 2009 | 54.75 Million USD | -45.59% |
| 2008 | 100.62 Million USD | -8.95% |
| 2007 | 110.51 Million USD | -1.54% |
| 2006 | 112.24 Million USD | 11.35% |
| 2005 | 100.8 Million USD | -51.99% |
| 2004 | 209.97 Million USD | 24.08% |
| 2003 | 169.23 Million USD | -48.47% |
| 2002 | 328.41 Million USD | -85.77% |
| 2001 | 2.3 Billion USD | -3.97% |
| 2000 | 2.4 Billion USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 60.47 Million USD | 3.97% |
| 2024 Q2 | 58.16 Million USD | 6.05% |
| 2024 Q1 | 54.84 Million USD | -14.19% |
| 2023 Q1 | 63.4 Million USD | -12.43% |
| 2023 FY | 63.91 Million USD | -11.72% |
| 2023 Q4 | 63.91 Million USD | 4.06% |
| 2023 Q3 | 61.42 Million USD | -8.75% |
| 2023 Q2 | 67.31 Million USD | 6.17% |
| 2022 Q2 | 72.68 Million USD | -0.41% |
| 2022 FY | 72.39 Million USD | -2.77% |
| 2022 Q3 | 73.27 Million USD | 0.82% |
| 2022 Q4 | 72.39 Million USD | -1.2% |
| 2022 Q1 | 72.98 Million USD | -1.99% |
| 2021 Q4 | 74.46 Million USD | -4.7% |
| 2021 FY | 74.46 Million USD | -2.89% |
| 2021 Q3 | 78.13 Million USD | 5.26% |
| 2021 Q1 | 76.1 Million USD | -0.75% |
| 2021 Q2 | 74.23 Million USD | -2.46% |
| 2020 Q3 | 74.25 Million USD | 9.17% |
| 2020 Q4 | 76.67 Million USD | 3.27% |
| 2020 Q1 | 68.02 Million USD | -2.52% |
| 2020 FY | 76.67 Million USD | 9.89% |
| 2020 Q2 | 68.01 Million USD | -0.01% |
| 2019 Q4 | 69.77 Million USD | -2.04% |
| 2019 Q3 | 71.23 Million USD | 2.39% |
| 2019 Q2 | 69.57 Million USD | -0.71% |
| 2019 Q1 | 70.06 Million USD | 31.81% |
| 2019 FY | 69.77 Million USD | 31.27% |
| 2018 Q2 | 57.43 Million USD | 1.46% |
| 2018 Q4 | 53.15 Million USD | -11.78% |
| 2018 Q1 | 56.61 Million USD | -5.69% |
| 2018 FY | 53.15 Million USD | -11.45% |
| 2018 Q3 | 60.25 Million USD | 4.9% |
| 2017 Q1 | 59.86 Million USD | -9.3% |
| 2017 FY | 60.03 Million USD | -9.04% |
| 2017 Q4 | 60.03 Million USD | -2.62% |
| 2017 Q3 | 61.64 Million USD | 3.24% |
| 2017 Q2 | 59.71 Million USD | -0.25% |
| 2016 Q3 | 58.67 Million USD | 1.41% |
| 2016 Q2 | 57.86 Million USD | 5.88% |
| 2016 Q1 | 54.64 Million USD | -3.91% |
| 2016 FY | 66 Million USD | 16.06% |
| 2016 Q4 | 66 Million USD | 12.48% |
| 2015 Q1 | 53.21 Million USD | -9.54% |
| 2015 FY | 56.86 Million USD | -3.33% |
| 2015 Q4 | 56.86 Million USD | -1.59% |
| 2015 Q3 | 57.79 Million USD | -5.52% |
| 2015 Q2 | 61.16 Million USD | 14.93% |
| 2014 Q4 | 58.83 Million USD | 3.41% |
| 2014 Q1 | 53.85 Million USD | -5.43% |
| 2014 FY | 58.83 Million USD | 3.31% |
| 2014 Q2 | 55.53 Million USD | 3.11% |
| 2014 Q3 | 56.89 Million USD | 2.45% |
| 2013 Q2 | 59 Million USD | -15.27% |
| 2013 FY | 56.94 Million USD | -20.03% |
| 2013 Q4 | 56.94 Million USD | -5.91% |
| 2013 Q3 | 60.52 Million USD | 2.58% |
| 2013 Q1 | 69.63 Million USD | -2.21% |
| 2012 Q4 | 71.2 Million USD | 30.63% |
| 2012 FY | 71.2 Million USD | -27.06% |
| 2012 Q1 | 61.19 Million USD | -37.31% |
| 2012 Q2 | 59.36 Million USD | -2.98% |
| 2012 Q3 | 54.51 Million USD | -8.18% |
| 2011 FY | 97.62 Million USD | 110.99% |
| 2011 Q2 | 105.1 Million USD | -12.97% |
| 2011 Q4 | 97.62 Million USD | 1.47% |
| 2011 Q3 | 96.2 Million USD | -8.47% |
| 2011 Q1 | 120.77 Million USD | 161.02% |
| 2010 Q2 | 47.52 Million USD | -2.41% |
| 2010 Q1 | 48.7 Million USD | -11.05% |
| 2010 Q3 | 43.61 Million USD | -8.24% |
| 2010 Q4 | 46.26 Million USD | 6.09% |
| 2010 FY | 46.26 Million USD | -15.5% |
| 2009 Q4 | 54.75 Million USD | 2.92% |
| 2009 FY | 54.75 Million USD | -45.59% |
| 2009 Q3 | 53.19 Million USD | -8.25% |
| 2009 Q2 | 57.98 Million USD | -40.24% |
| 2009 Q1 | 97.03 Million USD | -3.57% |
| 2008 Q2 | 100.01 Million USD | -3.63% |
| 2008 Q3 | 112.43 Million USD | 12.42% |
| 2008 Q4 | 100.62 Million USD | -10.51% |
| 2008 FY | 100.62 Million USD | -8.95% |
| 2008 Q1 | 103.78 Million USD | -6.09% |
| 2007 Q2 | 141.91 Million USD | -2.67% |
| 2007 Q1 | 145.8 Million USD | 29.91% |
| 2007 Q3 | 114.53 Million USD | -19.29% |
| 2007 Q4 | 110.51 Million USD | -3.51% |
| 2007 FY | 110.51 Million USD | -1.54% |
| 2006 Q2 | 189.28 Million USD | 75.58% |
| 2006 Q1 | 107.8 Million USD | 6.95% |
| 2006 Q3 | 105.19 Million USD | -44.43% |
| 2006 Q4 | 112.24 Million USD | 6.7% |
| 2006 FY | 112.24 Million USD | 11.35% |
| 2005 FY | 100.8 Million USD | -51.99% |
| 2005 Q4 | 100.8 Million USD | -9.84% |
| 2005 Q3 | 111.79 Million USD | -14.69% |
| 2005 Q2 | 131.04 Million USD | -18.39% |
| 2005 Q1 | 160.57 Million USD | -23.52% |
| 2004 FY | 209.97 Million USD | 24.08% |
| 2004 Q4 | 209.97 Million USD | 0.0% |
| 2003 FY | 169.23 Million USD | -48.47% |
| 2002 FY | 328.41 Million USD | -85.77% |
| 2001 FY | 2.3 Billion USD | -3.97% |
| 2000 FY | 2.4 Billion USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Augmedix, Inc. | 43.39 Million USD | -47.296% |
| OneMedNet Corporation | 13.32 Million USD | -379.731% |
| Minerva Surgical, Inc. | 51.71 Million USD | -23.577% |
| CareCloud, Inc. | 37.79 Million USD | -69.095% |
| CareCloud, Inc. | 37.79 Million USD | -69.095% |
| HealthEquity, Inc. | 1.2 Billion USD | 94.68% |
| iCoreConnect Inc. | 11.24 Million USD | -468.503% |
| Progyny, Inc. | 203.19 Million USD | 68.545% |
| Renalytix Plc | 15.82 Million USD | -303.848% |
| Schrödinger, Inc. | 254.39 Million USD | 74.877% |
| Simulations Plus, Inc. | 14.2 Million USD | -349.838% |
| SOPHiA GENETICS SA | 54.71 Million USD | -16.813% |
| Omnicell, Inc. | 1.03 Billion USD | 93.842% |
| BrightSpring Health Services, Inc. Common Stock | 5.17 Billion USD | 98.766% |
| Streamline Health Solutions, Inc. | 22.92 Million USD | -178.78% |
| Inovalon Holdings, Inc. | 1.26 Billion USD | 94.938% |
| Ontrak, Inc. | 5.57 Million USD | -1046.422% |
| Nutex Health, Inc. | 319.13 Million USD | 79.973% |
| GE HealthCare Technologies Inc. | 25.14 Billion USD | 99.746% |
| Sharecare, Inc. | 125.56 Million USD | 49.1% |
| Aclarion, Inc. | 3.18 Million USD | -1904.945% |
| CareMax, Inc. | 561.85 Million USD | 88.625% |
| Bullfrog AI Holdings, Inc. Common Stock | 184.35 Thousand USD | -34569.379% |
| Forian Inc. | 33.19 Million USD | -92.53% |
| Bullfrog AI Holdings, Inc. Warrants | 184.35 Thousand USD | -34569.379% |
| HeartBeam, Inc. | 1.19 Million USD | -5252.848% |
| GeneDx Holdings Corp. | 245.65 Million USD | 73.983% |
| SCWorx Corp. | 2.42 Million USD | -2535.842% |
| Definitive Healthcare Corp. | 626.72 Million USD | 89.802% |
| 10x Genomics, Inc. | 224.1 Million USD | 71.48% |
| Zhongchao Inc. | 3.37 Million USD | -1791.772% |
| Accolade, Inc. | 342.68 Million USD | 81.349% |
| MSP Recovery, Inc. | 1.74 Billion USD | 96.329% |
| R1 RCM Inc. | 2.2 Billion USD | 97.106% |
| Privia Health Group, Inc. | 392.51 Million USD | 83.717% |
| EUDA Health Holdings Limited | 8.79 Million USD | -626.908% |
| TruBridge, Inc. | 247.8 Million USD | 74.208% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 5.17 Billion USD | 98.766% |
| Sharecare, Inc. | 125.56 Million USD | 49.1% |
| Health Catalyst, Inc. | 334.89 Million USD | 80.916% |
| GoodRx Holdings, Inc. | 826.84 Million USD | 92.27% |
| Premier, Inc. | 1.46 Billion USD | 95.641% |
| HealthStream, Inc. | 159.19 Million USD | 59.851% |
| Certara, Inc. | 516.29 Million USD | 87.621% |
| GeneDx Holdings Corp. | 245.65 Million USD | 73.983% |
| Ontrak, Inc. | 5.57 Million USD | -1046.422% |
| SHL Telemedicine Ltd. | 36.58 Million USD | -74.682% |
| CareCloud, Inc. | 37.79 Million USD | -69.095% |
| EUDA Health Holdings Limited | 8.79 Million USD | -626.908% |
| HeartBeam, Inc. | 1.19 Million USD | -5252.848% |
| Mangoceuticals, Inc. | 276.03 Thousand USD | -23053.612% |
| CareMax, Inc. | 561.85 Million USD | 88.625% |
| Healthcare Triangle, Inc. | 9.51 Million USD | -571.99% |
| National Research Corporation | 73.48 Million USD | 13.022% |
| Aclarion, Inc. | 3.18 Million USD | -1904.945% |
| OptimizeRx Corporation | 56.82 Million USD | -12.482% |